Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Hashimoto

Showing results (221-230 of 330) with videos related to

Pageof 33
Sort By:
Urologic Oncology|July 16, 2020
Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancerNaoki Fujita, Shingo Hatakeyama, Kazutaka Okita, et al.
Urologic Oncology|December 14, 2020
Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancerHirotaka Horiguchi, Shingo Hatakeyama, Tohru Yoneyama, et al.
Lower Urinary Tract Symptoms|June 5, 2020
Overactive bladder and sleep disturbance have a significant effect on indoor falls: Results from the community health survey in JapanSakae Konishi, Shingo Hatakeyama, Atsushi Imai, et al.
International Journal of Clinical Oncology|October 28, 2019
Influence of pretreatment quality of life on prognosis in patients with urothelial carcinomaSappaya Suppanuntaroek, Shingo Hatakeyama, Naoki Fujita, et al.
Urologic Oncology|December 23, 2020
Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 yearsKyo Togashi, Shingo Hatakeyama, Teppei Okamoto, et al.
Scientific Reports|March 1, 2023
Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomyTakuya Oishi, Shingo Hatakeyama, Ryuji Tabata, et al.
Cancer Medicine|January 17, 2021
N-glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomasHirotake Kodama, Tohru Yoneyama, Toshikazu Tanaka, et al.
Oncology Research|February 10, 2011
Invadopodia formation by bladder tumor cellsMihoko Sutoh, Yasuhiro Hashimoto, Takahiro Yoneyama, et al.
Urologic Oncology|April 13, 2020
Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancerNaoki Fujita, Shingo Hatakeyama, Masaki Momota, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 6, 2020
Geriatric 8 screening of frailty in patients with prostate cancerMasaki Momota, Shingo Hatakeyama, Osamu Soma, et al.
Pageof 33

Showing results (221-230 of 330) with videos related to

Sort By:
Pageof 33
Urologic Oncology|July 16, 2020
Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancerNaoki Fujita, Shingo Hatakeyama, Kazutaka Okita, et al.
Urologic Oncology|December 14, 2020
Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancerHirotaka Horiguchi, Shingo Hatakeyama, Tohru Yoneyama, et al.
Lower Urinary Tract Symptoms|June 5, 2020
Overactive bladder and sleep disturbance have a significant effect on indoor falls: Results from the community health survey in JapanSakae Konishi, Shingo Hatakeyama, Atsushi Imai, et al.
International Journal of Clinical Oncology|October 28, 2019
Influence of pretreatment quality of life on prognosis in patients with urothelial carcinomaSappaya Suppanuntaroek, Shingo Hatakeyama, Naoki Fujita, et al.
Urologic Oncology|December 23, 2020
Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 yearsKyo Togashi, Shingo Hatakeyama, Teppei Okamoto, et al.
Scientific Reports|March 1, 2023
Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomyTakuya Oishi, Shingo Hatakeyama, Ryuji Tabata, et al.
Cancer Medicine|January 17, 2021
N-glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomasHirotake Kodama, Tohru Yoneyama, Toshikazu Tanaka, et al.
Oncology Research|February 10, 2011
Invadopodia formation by bladder tumor cellsMihoko Sutoh, Yasuhiro Hashimoto, Takahiro Yoneyama, et al.
Urologic Oncology|April 13, 2020
Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancerNaoki Fujita, Shingo Hatakeyama, Masaki Momota, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 6, 2020
Geriatric 8 screening of frailty in patients with prostate cancerMasaki Momota, Shingo Hatakeyama, Osamu Soma, et al.
Pageof 33